Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Other Non-Current Liabilities (2018 - 2026)

Alector's (ALEC) quarterly Other Non-Current Liabilities came in at $2.0 million in Q2 2026, up 40.17% year-over-year from $1.4 million in Q2 2025, and up 14.35% quarter-over-quarter from $1.8 million in Q1 2026.

Analysis

Alector (ALEC) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Other Non-Current Liabilities for 9 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 40.17% year-over-year to $2.0 million in Q2 2026; TTM through Jun 2026 was $2.0 million, a 40.17% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 40.76% from the prior year.
  • Other Non-Current Liabilities was $2.0 million for Q2 2026 at Alector, up from $1.8 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $2.0 million in Q2 2026 and troughed at $158000.0 in Q1 2022.
  • A 5-year average of $1.1 million and a median of $1.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities soared 468.35% in 2023 and declined 10.12% in 2024, its largest moves.
  • Over 5 years, Other Non-Current Liabilities stood at $759000.0 in 2022, then surged by 80.9% to $1.4 million in 2023, then decreased by 10.12% to $1.2 million in 2024, then soared by 40.76% to $1.7 million in 2025, then climbed by 16.52% to $2.0 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $2.0 million (Q2 2026), $1.8 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Alector 274.68 Mn 101.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.02 Mn
Mar 31, 2026 1.77 Mn
Dec 31, 2025 1.74 Mn
Sep 30, 2025 1.44 Mn
Jun 30, 2025 1.44 Mn
Mar 31, 2025 1.39 Mn
Dec 31, 2024 1.23 Mn
Sep 30, 2024 1.23 Mn
Jun 30, 2024 1.23 Mn
Mar 31, 2024 1.37 Mn
Dec 31, 2023 1.37 Mn
Sep 30, 2023 898,000.00
Jun 30, 2023 898,000.00
Mar 31, 2023 898,000.00
Dec 31, 2022 759,000.00
Sep 30, 2022 233,000.00
Jun 30, 2022 233,000.00
Mar 31, 2022 158,000.00
Dec 31, 2021 158,000.00
Sep 30, 2021 158,000.00